Question 1

What are the most cited papers from ActoGeniX (Belgium)?

Accepted Answer

The most cited paper from ActoGeniX (Belgium) is "Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis" (Klaas Vandenbroucke, Hans de Haard, Els Beirnaert et al., 2009), with 291 citations. Next come "Lactocepin Secreted By Lactobacillus Exerts Anti-Inflammatory Effects By Selectively Degrading Proinflammatory Chemokines" (240) and "Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice" (201).

Question 2

Which research topics does ActoGeniX (Belgium) publish most on?

Accepted Answer

By volume in 2022-now: Muscle activation and electromyography studies, Prosthetics and Rehabilitation Robotics and Mechanical Circulatory Support Devices.

Question 3

Which fields of science does ActoGeniX (Belgium) work in?

Accepted Answer

In all years, 56% of research at ActoGeniX (Belgium) is in Life Sciences, 42% in Health Sciences. Its largest fields are Medicine (31%), Biochemistry, Genetics and Molecular Biology (31%), Immunology and Microbiology (11%). It does 1.9× the world's share of Life Sciences.